KASINGER JAMES R.

PrivateCIK: 1708172
Location

CAMBRIDGE, MA

KASINGER JAMES R. (General Counsel and Secretary) sold 3.3% of their position (3.18K shares) of CRISPR THERAPEUTICS AG on the open market

Open‑market sale worth $148.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 1 sale
InsiderKASINGER JAMES R.CIK 1708172
IssuerCRISPR THERAPEUTICS AGCIK 1674416
Officer· General Counsel and Secretary
Since Feb 2026
+60.32K
Net shares
Net buyer
$148.9K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
69.75K acquired · 9.43K disposed
Non-Derivative Transactions2

Common Shares

Direct
M · Option Exercise

Shares

+6.25K

Price / share

Trade value

% of position

6.9%
3/20/2026
91.24K97.49K

Common Shares

Direct
S · Sale

Shares

3.18K

Price / share

$46.78

Trade value

$148.85K

% of position

3.3%
3/23/2026
97.49K94.31K
Total

Net shares

+3.07K

Net value

-$148.85K

Derivative Transactions3

Stock Option (Right to Buy)

Direct
A · Award
Converts to

Common Shares

38.50K shares

Shares

+38.50K

Strike price

46.24

Held after

38.50K

Exercisable

3/20/2026

Restricted Stock Units

Direct
A · Award
Converts to

Common Shares

25K shares

Shares

+25K

Strike price

Held after

25K

Exercisable

3/20/2026

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Common Shares

6.25K shares

Shares

6.25K

Strike price

Held after

12K

Exercisable

3/20/2026
KASINGER JAMES R. — Insider Transaction (Form 4) Filed Mar 24, 2026 | Finecho